These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6607939)

  • 1. Contribution of molecular biology to the understanding and control of microbial infections.
    Pittard AJ
    J Dent Res; 1984 Mar; 63(3):374-7. PubMed ID: 6607939
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbial resistance to antibiotic agents.
    Cohen S
    Compr Ther; 1979 May; 5(5):59-68. PubMed ID: 313309
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of infectious diseases: Introduction.
    Causey WA; Lerner SA; Kieff E
    Compr Ther; 1976 May; 2(5):7-10. PubMed ID: 1277775
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biochemical and genetical study on antibiotic-resistance in pathogenic bacteria, especially on the resistance to beta-lactam antibiotics by beta-lactamases (author's transl)].
    Sawai T; Yamagishi S
    Nihon Saikingaku Zasshi; 1981 Sep; 36(5):663-83. PubMed ID: 6977045
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccinia virus expression vectors.
    Mackett M; Smith GL
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2067-82. PubMed ID: 3531399
    [No Abstract]   [Full Text] [Related]  

  • 6. Versatile vaccine.
    Newmark P
    Microbiol Sci; 1984 Apr; 1(1):25. PubMed ID: 6444091
    [No Abstract]   [Full Text] [Related]  

  • 7. Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection.
    Ramshaw IA; Andrew ME; Phillips SM; Boyle DB; Coupar BE
    Nature; 1987 Oct 8-14; 329(6139):545-6. PubMed ID: 3498904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiviral properties of fucidin].
    Goncharskaia TIa; Navashin SM
    Antibiotiki; 1971 Jan; 16(1):57-60. PubMed ID: 4324189
    [No Abstract]   [Full Text] [Related]  

  • 9. Background of the antisense oligonucleotide approach to chemotherapy.
    Zamecnik P
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):199-202. PubMed ID: 9212910
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.
    Hooper JW; Custer DM; Schmaljohn CS; Schmaljohn AL
    Virology; 2000 Jan; 266(2):329-39. PubMed ID: 10639319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vaccinia virus as a vector for antiviral vaccines].
    Gendon IuZ
    Vopr Virusol; 1989; 34(4):396-404. PubMed ID: 2686162
    [No Abstract]   [Full Text] [Related]  

  • 12. [Epidemiologic problems of bacteria resistant to antibiotics: the concept of transposons].
    Piffaretti JC
    Ther Umsch; 1982 Sep; 39(9):700-7. PubMed ID: 6294897
    [No Abstract]   [Full Text] [Related]  

  • 13. Microbial resistance: bacteria and more.
    Wood MJ; Moellering RC
    Clin Infect Dis; 2003 Jan; 36(Suppl 1):S2-3. PubMed ID: 12516024
    [No Abstract]   [Full Text] [Related]  

  • 14. New approaches to the control of infections caused by antibiotic-resistant bacteria. An industry perspective.
    Chopra I; Hodgson J; Metcalf B; Poste G
    JAMA; 1996 Feb; 275(5):401-3. PubMed ID: 8569021
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combined effect of distamycin A and rifampicin on vaccinia virus in tissue culture cells].
    Goncharskaia TIa; Navashin SM
    Antibiotiki; 1973 Apr; 18(4):291-3. PubMed ID: 4767279
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanism in expression of drug resistance of bacteria and basic chemotherapy of bacterial infections].
    Yokota T
    Nihon Naika Gakkai Zasshi; 1990 Dec; 79(12):1620-6. PubMed ID: 1964165
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the antiviral activity of formycin.
    Ishida N; Homma M; Kumagai K; Shimizu Y; Matsumoto S
    J Antibiot (Tokyo); 1967 Jan; 20(1):49-52. PubMed ID: 4292904
    [No Abstract]   [Full Text] [Related]  

  • 18. siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects.
    Dave RS; McGettigan JP; Qureshi T; Schnell MJ; Nunnari G; Pomerantz RJ
    Virology; 2006 May; 348(2):489-97. PubMed ID: 16480752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of isatin beta thiosemicarbazone (IBT)-related compounds on IBT-resistant and on IBT-dependent mutants of vaccinia virus.
    Katz E; Margalith E; Winer B
    J Gen Virol; 1974 Nov; 25(2):239-44. PubMed ID: 4373528
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new clinico-pharmacological method for the evaluation of the antiviral activity of distamycin A].
    Mars G; Regoli U
    Clin Ter; 1968 Jun; 44(6):573-80. PubMed ID: 5736875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.